PCN97 ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CETUXIMAB TREATMENT DECISION MODEL: CHEMOTHERAPY+CETUXIMAB VS. CETUXIMAB TREAT-TO-RASH STRATEGY VS. CHEMOTHERAPY ONLY IN FIRST-LINE TREATMENT OF STAGE IIIB/IV NSCLC

• 作者J Roth; J Carlson
• 卷第13卷
• 期第3期
• 文件大小78.18KB
• 发表时间2010
• DOI10.1016/s1098-3015(10)72186-0